Literature DB >> 15210535

Stiff-person syndrome following West Nile fever.

Sharon Hassin-Baer1, Eilon D Kirson, Lester Shulman, Aron S Buchman, Hanna Bin, Musa Hindiyeh, Lea Markevich, Ella Mendelson.   

Abstract

BACKGROUND: Stiff-person syndrome is a rare autoimmune disorder associated with antibodies against glutamic acid decarboxylase (GAD), the key enzyme in gamma-aminobutyric acid synthesis. In most cases, a trigger cannot be identified.
OBJECTIVE: To describe a 41-year-old man who developed stiff-person syndrome and antibodies to GAD following acute West Nile virus infection.
DESIGN: A case report and a search in GenBank for common epitopes. RESULT: The search revealed a stretch of 12 amino acids in the NS1 protein of West Nile virus with a high degree of homology to the GAD65 region (an isoform of GAD) containing the PEVKEK motif.
CONCLUSION: Cross-reactivity between antibodies directed against West Nile virus and GAD may have contributed to the development of stiff-person syndrome in this patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210535     DOI: 10.1001/archneur.61.6.938

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.

Authors:  Goran Rakocevic; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

2.  Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.

Authors:  Eleni E Magira; Harry Alexopoulos; Evangelos Charitatos; Dimitris Michas; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 3.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

4.  Presumed case of "stiff-horse syndrome" caused by decreased gamma-aminobutyric acid (GABA) production in an American Paint mare.

Authors:  Tawna Backman Purcell; Ann Davidson Sellers; Lutz S Goehring
Journal:  Can Vet J       Date:  2012-01       Impact factor: 1.008

5.  Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.

Authors:  S Michalak; S Cofta; A Piatek; J Rybacka; E Wysocka; W Kozubski
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

6.  Neuromuscular Manifestations of Human West Nile Virus Infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

7.  Neuromuscular manifestations of west nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

8.  Seropositivity for West Nile Virus Antibodies in Patients Affected by Myasthenia Gravis.

Authors:  Marilena Greco; Pietro Cofano; Giambattista Lobreglio
Journal:  J Clin Med Res       Date:  2016-01-26

9.  Tumor Necrosis Factor-Alpha Signaling May Contribute to Chronic West Nile Virus Post-infectious Proinflammatory State.

Authors:  A Arturo Leis; Marie F Grill; Brent P Goodman; Syed B Sadiq; David J Sinclair; Parminder J S Vig; Fengwei Bai
Journal:  Front Med (Lausanne)       Date:  2020-04-30

Review 10.  Current Understanding of West Nile Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications.

Authors:  Fengwei Bai; E Ashley Thompson; Parminder J S Vig; A Arturo Leis
Journal:  Pathogens       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.